Concepedia
Statistics
Publications
35
Citations
2.3K
H-Index
27
Active since
2011
Affiliations
The Netherlands Cancer Institute(Current)
Utrecht University
Oncode Institute
Pharmo Institute
Leiden University Medical Center
Didier Meulendijks is an author at The Netherlands Cancer Institute specializing in medicine, oncology, and pharmacology.
Publications per year
2011–2024
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis
Linda M. Henricks, Carin A.T.C. Lunenburg, Femke M. de Man et al. · The Lancet Oncology · 2018 · 419 citations · Full text
Medicine, Oncology, Pharmacology +16
Upfront Genotyping of <i>DPYD</i>*<i>2A</i> to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis
Maarten J. Deenen, Didier Meulendijks, Annemieke Cats et al. · Journal of Clinical Oncology · 2015 · 345 citations · Full text
Medicine, Oncology, Pharmacology +17
Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity
Didier Meulendijks, Linda M. Henricks, Bart Jacobs et al. · British Journal of Cancer · 2017 · 122 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +15
HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53
Didier Meulendijks, N B Tomasoa, L. Dewit et al. · British Journal of Cancer · 2015 · 113 citations · Full text
Medicine, Oncology, Pathology +17
Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option
Didier Meulendijks, L. Dewit, N B Tomasoa et al. · British Journal of Cancer · 2014 · 93 citations · Full text
Medicine, Oncology, Pharmacotherapy +17
1–5 of 35